National Peroxide Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024
Revenue	2,869	3,330
Revenue Growth (YoY)	-13.85%	-
Cost of Revenue	2,007	2,149
Gross Profit	861.86	1,180
Selling, General & Admin	303.03	289.6
Other Operating Expenses	406.73	514.96
Operating Expenses	910.84	997.15
Operating Income	-48.98	183.32
Interest Expense	-16.65	-19.82
Other Non Operating Income (Expenses)	44.87	51.63
Pretax Income	-20.77	215.14
Income Tax Expense	1.7	47.24
Net Income	-22.46	167.9
Net Income to Common	-22.46	167.9
Shares Outstanding (Basic)	6	6
Shares Outstanding (Diluted)	6	6
Shares Change (YoY)	-0.02%	-
EPS (Basic)	-3.91	29.22
EPS (Diluted)	-3.91	29.22
Free Cash Flow	137.78	217.7
Free Cash Flow Per Share	23.98	37.88
Gross Margin	30.04%	35.45%
Operating Margin	-1.71%	5.50%
Profit Margin	-0.78%	5.04%
Free Cash Flow Margin	4.80%	6.54%
EBITDA	152.1	375.92
EBITDA Margin	5.30%	11.29%
D&A For EBITDA	201.08	192.6
EBIT	-48.98	183.32
EBIT Margin	-1.71%	5.50%
Effective Tax Rate	-	21.96%
Revenue as Reported	2,914	3,381

Updated Jan 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.